Highlights Codexis, Inc.

Equities

CDXS

US1920051067

Market Closed - Nasdaq Other stock markets 01:00:00 2024-07-03 pm EDT			5-day change	1st Jan Change
2.88 ^USD	-0.35%		-4.32%	-5.57%

Jul. 01	Codexis Sells Fabry, Pompe Disease Compounds to Crosswalk Therapeutics	MT
May. 30	Cantor Fitzgerald Starts Codexis With Overweight Rating, $11 Price Target	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Codexis Sells Fabry, Pompe Disease Compounds to Crosswalk Therapeutics	Jul. 01	MT
Codexis, Inc. Presents Enzymatic Synthesis Data at TIDES USA Annual Meeting and Launches RNA Ligase Screening and Optimization Services	May. 14	CI
Earnings Flash (CDXS) CODEXIS Posts Q1 Revenue $17.1M, vs. Street Est of $13.3M	May. 02	MT
Codexis, Inc. Reiterates Financial Guidance for the Fiscal 2024	May. 02	CI
Codexis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02	CI
Earnings Flash (CDXS) CODEXIS Reports Q4 Revenue $26.6M, vs. Street Est of $18.9M	Feb. 28	MT
Codexis, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 28	CI
Codexis Shares Up 31% on Roche Licensing Agreement	Feb. 27	DJ
Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche	Feb. 26	CI
Roche Sequencing Solutions, Inc. entered into an agreement to acquire Global license of double-stranded DNA from Codexis, Inc.	Feb. 25	CI
SeqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting	Feb. 01	CI
Codexis, Inc. Announces Purchase Agreement with Nestle Health Science for Cdx-7108	Dec. 27	CI
Codexis Assigns Interests in Potential Exocrine Pancreatic Insufficiency Treatment to Nestle Health Science	Dec. 27	MT
Federal Reserve Outlook Pushes Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday	Dec. 14	MT
Codexis Signs Exclusive License Agreement With Aldevron for Codex HiCap RNA Polymerase; Shares Surge Premarket	Dec. 14	MT
Codexis Signs Exclusive License Agreement With Aldevron for Codex HiCap RNA Polymerase	Dec. 13	MT
Codexis, Inc. and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase	Dec. 13	CI
Aldevron, LLC entered into an agreement to acquire global exclusive license for Codex® HiCap RNA Polymerase from Codexis, Inc..	Dec. 12	CI
Codexis, Inc. Reiterates Earnings Guidance for the Year 2023	Nov. 02	CI
Earnings Flash (CDXS) CODEXIS Posts Q3 Revenue $9.3M, vs. Street Est of $10M	Nov. 02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Codexis, Inc.

Equities

CDXS

US1920051067

Highlights

Filters